10 Best Healthcare Stocks to Buy According to Billionaires

6. Boston Scientific Corporation (NYSE:BSX)

Number of Billionaire Investors: 17

Value of Billionaire Holdings: $3.2 billion

Boston Scientific Corporation (NYSE:BSX) is a Massachusetts-based company that specializes in developing, manufacturing, and distributing medical devices for interventional procedures worldwide. It operates through two segments – MedSurg and Cardiovascular. On February 6, Canaccord Genuity maintained its Buy rating on the stock and increased the price target from $101 to $117, citing the company’s strong fourth-quarter earnings.

Boston Scientific Corporation (NYSE:BSX) reported net sales of approximately $4.6 billion in the fourth quarter of 2024, a 22.4% increase from the same period last year. GAAP net income attributable to common stockholders was $566 million, or $0.38 per share, up from $504 million, or $0.34 per share, a year earlier. Q4 adjusted EPS rose to $0.7 from $0.55 in the prior year. For the full year 2024, net sales reached $16.75 billion, reflecting a 17.6% year-over-year growth. With its strong financial performance and consistent growth, BSX remains one of the best healthcare stocks in the market.

On March 3, Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire SoniVie Ltd., a privately held medical device company. SoniVie has developed the TIVUS Intravascular Ultrasound System, an investigational technology designed to target nerves surrounding blood vessels for the treatment of hypertensive conditions.